- Home
- NBIX vs GLPI Comparison
NBIX vs GLPI Comparison
Compare NBIX & GLPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- GLPI
- Stock Information
- Founded
- NBIX 1992
- GLPI 2013
- Country
- NBIX United States
- GLPI United States
- Employees
- NBIX N/A
- GLPI N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- GLPI Real Estate Investment Trusts
- Sector
- NBIX Health Care
- GLPI Real Estate
- Exchange
- NBIX Nasdaq
- GLPI Nasdaq
- Market Cap
- NBIX 11.0B
- GLPI 13.1B
- IPO Year
- NBIX 1996
- GLPI N/A
- Fundamental
- Price
- NBIX $115.71
- GLPI $46.89
- Analyst Decision
- NBIX Strong Buy
- GLPI Buy
- Analyst Count
- NBIX 20
- GLPI 19
- Target Price
- NBIX $163.20
- GLPI $53.61
- AVG Volume (30 Days)
- NBIX 1.8M
- GLPI 1.7M
- Earning Date
- NBIX 05-05-2025
- GLPI 04-24-2025
- Dividend Yield
- NBIX N/A
- GLPI 6.48%
- EPS Growth
- NBIX N/A
- GLPI 4.14
- EPS
- NBIX 2.96
- GLPI 2.83
- Revenue
- NBIX $2,412,600,000.00
- GLPI $1,550,817,000.00
- Revenue This Year
- NBIX $15.36
- GLPI $6.89
- Revenue Next Year
- NBIX $16.34
- GLPI $3.73
- P/E Ratio
- NBIX $39.66
- GLPI $16.43
- Revenue Growth
- NBIX 21.73
- GLPI 6.14
- 52 Week Low
- NBIX $84.23
- GLPI $42.86
- 52 Week High
- NBIX $157.98
- GLPI $52.60
- Technical
- Relative Strength Index (RSI)
- NBIX 60.88
- GLPI 41.50
- Support Level
- NBIX $105.45
- GLPI $46.21
- Resistance Level
- NBIX $130.46
- GLPI $47.13
- Average True Range (ATR)
- NBIX 4.31
- GLPI 0.91
- MACD
- NBIX 1.96
- GLPI -0.12
- Stochastic Oscillator
- NBIX 50.22
- GLPI 17.99
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.